GlobalData

The ongoing early study only requires 30 COVID-19 cases to detect vaccine efficacy, which is much too small to be sure of…

AI start-ups are helping pharma companies to digitally bridge the gap between thousands of repurposed drug molecules, clinical…

Indian pharma companies are more likely to engage in contract/excess capacity API manufacture than companies in the other small…

The number of trials that have been impacted by slow enrollment has increased by 13.9 per cent

There are 13 Indian organisations working on COVID-19 vaccine development

Big pharma companies are searching for innovative biotechs to invest in the rare diseases space

Both drugs have seen a sharp decline in price since the availability of the first generic in India

New data suggest that some hard-hit communities may be better protected for COVID-19 resurgence, while other communities are not

By the end of March 2020, Semglee was approved in 60 countries and launched in several countries including the EU, Australia and…

High-risk groups include older patients, those with pre-existing conditions, at-risk ethnicities and healthcare workers